Results for the Quarter Ended 30th June, 2026
As filed · Balaji Amines Limited has submitted to the Exchange, Results for the Quarter Ended 30th June, 2026
What happened
FactThe filing indicates a change in the company secretary at Balajiamines. It also includes details about the un-audited standalone and consolidated financial results for the quarter ended June 30, 2026, along with the limited review reports from the statutory auditors. The board meeting regarding these matters commenced at 4:30 P.M. and concluded at 5:35 P.M.
Why it matters
CapitSignal interpretationReported results are the point at which prior management commitments become checkable against audited or reviewed numbers.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Capex
DelayedN-Methyl Morpholine (NMM) 5000 TPA is under execution and expected to be commissioned during FY 2026-27.
Acetonitrile (ACN) Improved process based New ACN plant is under execution, the same is expected to be commissioned during the Second Quarter of FY 2026-27.
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Margin trend against the prior period
- Cash from operations against reported profit
- Whether prior guidance is reaffirmed
- We have a 100,000 TPA capacity, which we plan to operate at about 70% in the subsequent fiscal (FY27). (management committed by FY27)
Evidence
- Balaji Amines Limited has submitted to the Exchange, Results for the Quarter Ended 30th June, 2026(opens the original filing in a new tab)
- Earlier statement · Q4 FY26
- Latest statement · Q4 FY26
- Earlier statement · Q4 FY26
How CapitSignal classified this
- Reasoning:
- RESULTS base 68; +5 quantified amount; +3 quantified percentage; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%